Seven states and territories met the national benchmark
All states and territories achieved rates below the current nationally-agreed performance benchmark of 1.0 case per 10,000 patient days, except the Australian Capital Territory. Rates ranged from 0.62 in Western Australia to 1.08 in the Australian Capital Territory.
Trends over time
Overall, SABSI rates have decreased at the national level from 1.09 cases per 10,000 patient days in 2010–11 to 0.73 in 2021–22. Rates by state/territory fluctuate from year to year.
On 1 July 2020, the agreed national benchmark changed from no more than 2.0 cases of healthcare-associated SABSI per 10,000 days of patient care to no more than 1.0 case.
Since 2010–11, rates of healthcare-associated MRSA have also declined – from 0.29 cases per 10,000 patient days to 0.11 cases. These cases accounted for 27% of all SABSI cases in 2010–11 compared with 15% of all cases in 2021–22.